ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
2,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
2,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,3,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
6,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
7,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
8,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
10,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,Y
11,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
11,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
12,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
14,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,2,Tension headache,Headaches NEC,Headaches,Nerv,N
15,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
16,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
18,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
18,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
19,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
20,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
20,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
21,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
22,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
23,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
23,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
26,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
27,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
27,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
27,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
29,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
29,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
29,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
33,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
34,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
34,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
34,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
34,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
34,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
35,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
38,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
38,3,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Teratoma,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
40,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
40,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
42,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
42,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
42,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
44,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
45,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
46,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
48,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
48,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
49,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
50,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
51,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
52,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
53,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
55,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
55,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
56,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
57,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
58,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
58,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
58,3,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
59,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
61,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
61,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
62,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
62,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
63,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
64,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
64,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
66,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
67,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
69,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
70,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
71,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
72,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
73,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
74,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
75,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
76,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
77,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
78,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
80,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
82,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
85,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
86,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
87,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
87,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
87,3,Headache,Headaches NEC,Headaches,Nerv,N
87,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
88,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
89,2,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
89,3,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
90,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
90,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
90,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
91,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
92,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
92,3,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
93,1,Headache,Headaches NEC,Headaches,Nerv,N
93,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
93,4,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
94,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
94,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
94,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
94,4,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
95,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
96,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
97,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
97,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
98,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
99,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
100,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
101,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
102,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
103,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
105,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
106,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
106,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
107,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
108,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
109,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
110,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
111,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
112,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
116,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
117,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
118,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
119,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
121,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
122,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
123,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
124,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
125,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
126,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
126,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
127,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
128,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
129,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
130,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
131,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
132,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
133,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
134,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
136,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
137,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
138,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
139,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
139,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
141,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
141,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
142,1,Injection site fibrosis,Injection site reactions,Administration site reactions,Genrl,N
143,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
144,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
145,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
145,2,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
146,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
147,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
147,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
148,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
148,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
148,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
149,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
149,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
150,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
151,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
152,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
153,1,Femoral nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
153,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
153,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
153,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
153,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
153,6,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
153,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
154,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
155,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
156,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
157,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
158,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
158,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
158,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
159,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
160,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
161,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
161,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
161,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
161,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
162,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
163,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
163,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
164,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
165,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
165,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
166,1,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
168,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
169,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
170,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
171,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
171,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
172,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
173,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
173,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
174,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
175,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
176,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
177,1,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
178,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
178,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
178,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
180,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
181,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
182,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
182,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
183,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
184,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
186,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
186,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
186,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
187,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
188,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
188,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
189,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
190,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
191,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
191,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
192,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
193,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
194,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
194,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
195,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
197,1,Developmental hip dysplasia,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
198,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
199,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,1,Headache,Headaches NEC,Headaches,Nerv,N
200,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
200,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
200,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
202,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
203,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
204,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
205,1,Phlebitis superficial,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
206,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
207,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
208,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
210,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
211,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
212,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
212,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
213,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
214,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
215,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
216,1,Headache,Headaches NEC,Headaches,Nerv,N
217,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
218,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
219,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
220,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
221,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
222,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
223,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
224,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
225,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
226,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
227,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
228,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
228,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
229,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
229,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
229,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
230,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
230,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
232,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
233,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
234,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
235,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
236,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
237,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
237,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
238,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
238,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
239,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
239,2,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
239,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
239,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
239,5,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
240,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
240,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
240,3,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
240,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
240,5,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
241,1,Teratoma,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
242,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
242,2,Hypoaldosteronism,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
242,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
243,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
244,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
245,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
245,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
247,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
248,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
248,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
249,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
250,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
251,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
252,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
252,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
253,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
256,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
257,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
257,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
257,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
258,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
259,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
260,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
260,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
261,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
262,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
263,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
263,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
263,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
263,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
264,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
264,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
265,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
266,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
267,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
267,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
267,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
267,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
268,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
269,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
269,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
269,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
270,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
271,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
272,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
273,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
273,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
275,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
275,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
276,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
277,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
277,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
278,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
278,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
278,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
278,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
279,1,Anoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
279,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
279,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
280,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
281,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
282,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
283,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
284,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
285,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
286,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
287,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
288,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
289,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
290,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
290,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
291,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
292,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
293,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
293,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
294,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
295,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
295,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
295,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
295,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
295,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
295,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
296,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
298,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
299,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
300,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
302,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
303,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
303,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
303,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
303,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
303,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
304,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
305,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
306,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
306,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
306,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
307,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
307,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
310,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
310,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
311,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
312,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
313,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
313,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
314,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
315,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
315,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
316,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
317,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
318,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
319,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
320,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
321,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
322,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
322,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
323,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
323,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
324,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
325,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
325,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
326,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
327,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
328,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
329,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
329,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
329,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
330,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
330,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
331,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
332,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
333,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
333,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
334,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
335,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
336,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
337,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
338,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
338,2,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
339,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
339,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
339,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
340,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
341,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
342,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
342,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
342,3,Headache,Headaches NEC,Headaches,Nerv,N
342,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
343,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
344,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
344,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
344,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
344,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
345,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
346,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
346,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
347,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
348,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
349,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
350,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
351,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
352,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
352,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
353,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
353,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
354,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
354,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
355,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
356,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
357,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
357,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
358,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
358,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
358,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
359,1,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
359,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
360,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
360,2,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
360,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
360,4,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
361,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
362,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
362,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
362,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
362,4,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
363,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
363,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
364,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
365,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
365,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
365,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
365,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
366,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
366,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
366,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
366,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
367,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
368,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
368,2,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
368,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
368,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
368,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
369,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
369,2,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
370,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
371,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
371,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
372,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
372,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
372,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
373,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
374,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
375,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
375,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
376,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
376,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
377,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
378,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
379,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
381,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
381,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
382,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
382,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
382,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
383,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
384,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
385,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
386,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
387,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
388,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
389,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
389,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
390,1,Abnormal clotting factor,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
390,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
390,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
390,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
391,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
392,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
393,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
394,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
395,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
396,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
396,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
397,1,Epidural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
397,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
398,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
399,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
402,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
403,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
403,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
403,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
403,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,5,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
403,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
403,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
403,8,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
403,9,Renal vein occlusion,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
403,10,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
404,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
404,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
404,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
405,1,Anti-platelet antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
405,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
406,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
407,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
408,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
409,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,2,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
410,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
411,1,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
412,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
413,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
414,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
414,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
415,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
415,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
416,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
417,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
418,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
418,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
419,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
420,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
421,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
422,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
423,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,Y
424,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
425,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
426,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
426,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
426,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
426,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
426,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
426,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
427,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
428,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
429,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
429,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,3,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
429,4,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
429,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
429,6,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
430,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
430,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
431,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
431,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
431,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
432,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
433,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
434,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
435,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
436,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
436,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
436,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
437,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
438,1,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
439,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
440,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
440,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
441,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
442,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
442,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
442,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
443,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
443,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
443,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
443,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
443,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
443,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
443,7,Mediastinal haematoma,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
443,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
443,9,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
443,10,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
443,11,Oesophageal mass,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
443,12,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
443,13,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
444,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
444,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
445,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
446,1,Diaphragmatic paralysis,Diaphragmatic disorders,Thoracic disorders (excl lung and pleura),Resp,N
447,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
447,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
447,4,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
447,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
448,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
449,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
449,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
449,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
450,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
451,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
452,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
452,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
452,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
452,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
452,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
453,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
454,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
454,2,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
454,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
454,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
454,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
454,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
455,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
455,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
456,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
457,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
458,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
459,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
459,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
459,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
460,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
460,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
460,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
460,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
461,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
462,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
462,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
463,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
464,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,Y
464,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
465,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
466,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
466,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
466,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
467,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
467,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
467,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
468,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
468,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
468,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
469,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
469,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
469,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
469,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
470,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
470,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
471,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
471,2,Finger amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
471,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
472,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
472,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
472,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
472,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
472,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
473,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
473,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
473,3,Headache,Headaches NEC,Headaches,Nerv,N
473,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
473,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
474,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
475,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
476,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
476,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
476,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
476,4,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
476,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
477,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
478,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
479,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
480,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
481,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
482,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
483,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
484,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
485,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
486,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
487,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
487,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
487,3,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
487,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
487,5,Papillary muscle rupture,Myocardial disorders NEC,Myocardial disorders,Card,N
487,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
487,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
487,8,Ventricle rupture,Myocardial disorders NEC,Myocardial disorders,Card,N
488,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
489,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Infusion site hypersensitivity,Infusion site reactions,Administration site reactions,Genrl,N
490,2,Infusion site urticaria,Infusion site reactions,Administration site reactions,Genrl,N
490,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
491,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
492,1,Cardiac aneurysm,Myocardial disorders NEC,Myocardial disorders,Card,N
492,2,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
492,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
492,4,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
493,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
493,2,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
493,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
493,4,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
493,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
493,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
493,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
493,8,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
493,10,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
493,11,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
494,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
494,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
494,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
494,4,Uterine dilation and evacuation,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
494,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
495,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
495,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
495,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
496,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
496,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
496,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
497,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
497,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
497,3,Headache,Headaches NEC,Headaches,Nerv,N
498,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
499,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
500,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
501,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
501,2,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
501,3,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
502,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
503,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
503,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
503,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
503,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
503,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
504,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
504,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
504,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
504,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
505,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
505,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
505,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
505,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
505,5,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
505,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
506,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
506,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
507,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
508,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
509,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
509,2,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
509,3,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
509,4,Headache,Headaches NEC,Headaches,Nerv,N
509,5,Orbital haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
509,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
509,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
510,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
510,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
510,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
511,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
512,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
513,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
514,1,Abdominal wall haemorrhage,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
514,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
514,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
515,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
515,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
516,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
517,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
517,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
518,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
519,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
519,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
519,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
519,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
519,5,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
519,6,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
520,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
520,2,Cranial nerve palsies multiple,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
521,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
522,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
522,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
523,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
523,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
524,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
524,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
524,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
525,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
526,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
526,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
526,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
527,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
527,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
528,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
529,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
529,2,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
530,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
530,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
530,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
530,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
530,5,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
531,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
532,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
532,2,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
533,1,Catheter site haematoma,Implant and catheter site reactions,Administration site reactions,Genrl,N
533,2,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
533,3,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
533,4,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
533,5,Tracheal haemorrhage,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
534,1,Catheter site haematoma,Implant and catheter site reactions,Administration site reactions,Genrl,N
534,2,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
534,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
534,4,Tracheal haemorrhage,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
535,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
535,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
535,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
537,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
537,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
537,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
537,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
537,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
537,6,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
537,7,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
537,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
537,9,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
537,10,Peripheral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
537,11,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
537,12,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
538,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
539,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
540,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
540,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
541,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
541,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
541,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
542,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
543,1,Tongue haematoma,Tongue disorders,Tongue conditions,Gastr,N
544,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
544,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
544,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
544,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
545,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
545,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
545,3,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
545,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
545,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
545,6,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
545,7,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
545,8,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
546,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
546,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
547,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
548,1,Brain stem haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
548,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
548,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
548,4,Headache,Headaches NEC,Headaches,Nerv,N
548,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
549,1,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
550,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
550,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
551,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
552,1,Brain stem haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
552,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
552,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
552,4,Headache,Headaches NEC,Headaches,Nerv,N
552,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
553,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
554,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
555,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
556,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
556,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
556,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
557,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
558,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
558,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
559,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
559,2,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
559,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
559,4,Neurological complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
559,5,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
559,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
560,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
561,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
561,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
561,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
561,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
561,5,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
561,6,Mediastinal haemorrhage,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
562,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
563,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
564,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
565,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
566,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
566,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
567,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
568,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
568,2,Mediastinal haemorrhage,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
569,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
569,2,Mediastinal haemorrhage,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
570,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
571,1,Mediastinal haemorrhage,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
572,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
573,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
574,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
575,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
576,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
577,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
578,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
579,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
580,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
581,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
582,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
583,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
584,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
585,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
586,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
587,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
588,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
589,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
590,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
591,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
592,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
593,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
593,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
593,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
593,4,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
593,5,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
593,6,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
593,7,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
593,8,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
593,9,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
593,10,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
593,11,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
593,12,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
593,13,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
593,14,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
593,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
593,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
593,17,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
593,18,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
593,19,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
593,20,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
593,21,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
593,22,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
593,23,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
594,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
595,1,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
596,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
596,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
597,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
598,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
599,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
600,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
600,2,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
601,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
601,2,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
602,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
603,1,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
604,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
604,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
604,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
604,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
605,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
605,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
605,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
605,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
605,5,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
605,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
605,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
605,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
605,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
606,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
607,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
608,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
609,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
610,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
611,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
612,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
613,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
614,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
615,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
616,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
617,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
618,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
619,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
620,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
620,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
621,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
621,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
622,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
622,2,Foetal-maternal haemorrhage,Foetal complications NEC,Foetal complications,Preg,N
623,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
623,2,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
623,3,Breast haematoma,Breast signs and symptoms,Breast disorders,Repro,N
623,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
623,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
623,6,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
623,7,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
623,8,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
623,9,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
623,10,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
623,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
623,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
624,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
624,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
624,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
624,4,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
624,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
625,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
625,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
626,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
626,2,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
626,3,Congenital multiplex arthrogryposis,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
626,4,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
626,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
626,6,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
626,7,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
627,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
627,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
628,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
628,2,Interventricular septum rupture,Myocardial disorders NEC,Myocardial disorders,Card,N
628,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
629,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
630,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
630,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
630,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
631,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
631,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
632,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
632,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
632,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
633,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
634,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
634,2,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
634,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
635,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
635,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
636,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
636,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
637,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
638,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
638,2,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
639,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
639,2,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
639,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
639,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
639,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
639,7,Muscle oedema,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
639,8,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
639,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
639,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
639,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
640,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
640,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
641,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
641,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,3,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
642,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
642,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
643,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
643,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
643,3,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
644,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
644,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
645,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
646,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
646,2,Carbon dioxide increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
647,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
647,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
648,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
648,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
648,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
648,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
649,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
649,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
650,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
650,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
650,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
650,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
650,5,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
650,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
650,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
651,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
651,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
651,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
651,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
651,5,Muscle swelling,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
651,6,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
651,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
651,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
651,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
651,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
651,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
651,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
652,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
652,2,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
652,3,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
653,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
653,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
653,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
653,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
654,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,1,Air embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
655,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
655,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
655,4,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
656,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
656,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
657,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
657,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
657,3,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
657,4,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
658,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
658,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
658,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
658,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
659,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
660,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
661,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
661,2,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
662,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
662,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
662,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
663,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
664,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
664,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
665,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
666,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
667,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
667,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
668,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
668,2,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
668,3,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
669,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
669,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
669,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
670,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
671,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
672,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
673,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
673,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
673,3,Headache,Headaches NEC,Headaches,Nerv,N
673,4,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
673,5,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
673,6,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
673,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
674,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
675,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
675,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
676,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
677,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
678,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
678,2,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
679,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
679,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,Y
680,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
680,2,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
680,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
681,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
681,2,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
682,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
682,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
683,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
683,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
683,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
683,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
684,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
685,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
686,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
687,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,2,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
687,3,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
688,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
689,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
689,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
689,3,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
689,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
690,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
690,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
690,3,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
690,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
690,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
690,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
690,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
690,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
690,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
691,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
692,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
693,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
694,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
695,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
696,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
697,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
697,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
697,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
698,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
698,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
699,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
699,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
699,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
699,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
699,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
699,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
699,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
699,8,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
699,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
700,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
701,1,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
701,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
701,3,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,Y
702,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
703,1,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
704,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
704,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
704,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
705,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
705,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
705,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
705,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
705,5,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
705,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
705,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
705,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
705,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
706,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
706,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
706,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
707,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
707,2,Pelvic haematoma obstetric,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
708,1,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
709,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
709,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
709,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
709,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
709,5,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
709,6,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
709,7,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
709,8,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
709,9,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
709,10,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
709,11,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
709,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
709,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
709,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
709,15,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
709,16,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
709,17,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
709,18,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
709,19,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
709,20,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
709,21,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
709,22,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
709,23,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
709,24,Septic rash,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
709,25,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
709,26,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
710,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
710,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
710,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
710,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
710,5,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
711,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
711,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
712,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
713,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
713,2,Haemorrhagic ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
713,3,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
713,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
714,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
714,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
715,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
715,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
716,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
717,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
718,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
719,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
719,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
719,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
720,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
721,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
722,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
722,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
722,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
723,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
724,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
724,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
724,3,Haemodialysis complication,Dialysis related complications,Procedural related injuries and complications NEC,Inj&P,N
724,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
724,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
724,6,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
724,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
724,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
725,1,Carotid aneurysm rupture,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
725,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
725,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
725,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
725,5,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
725,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
726,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
726,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
726,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
727,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
727,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
727,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
728,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
729,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
729,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
730,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
731,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
731,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
731,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
731,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
731,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
733,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
734,1,Peristalsis visible,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
735,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
735,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
735,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
735,4,Headache,Headaches NEC,Headaches,Nerv,N
735,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
735,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
736,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
737,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
737,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
738,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
738,2,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
738,3,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
738,4,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
738,5,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
738,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
738,7,Subarachnoid haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
739,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
740,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
740,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
740,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
740,4,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
741,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
741,2,Anastomotic haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
741,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
741,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
741,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
741,6,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
742,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
743,1,Aortic valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
743,2,Traumatic haemothorax,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
744,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
745,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
745,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
746,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
746,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
747,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
747,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
748,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
748,2,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
748,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
748,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
749,1,Arteriovenous fistula site haemorrhage,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
749,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
750,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
750,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
750,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
751,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
752,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
753,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
754,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
754,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
754,3,Post procedural pulmonary embolism,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
755,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,2,Heparin resistance,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
755,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
756,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,2,Heparin resistance,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
756,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
757,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
757,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
757,4,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
758,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
759,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
760,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
760,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
761,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
761,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
761,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
762,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
762,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
763,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
763,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,4,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
764,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
764,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
765,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
766,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
767,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
767,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
767,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
767,4,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
767,5,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
768,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
769,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
769,3,Product quality control issue,Manufacturing production issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
770,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
770,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
770,3,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
771,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
771,4,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
772,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
773,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
773,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
774,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
775,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
775,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
776,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
777,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
778,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
778,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
778,4,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
779,1,Arteriovenous fistula site haematoma,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
779,2,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,N
779,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
779,4,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
779,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
779,6,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
779,7,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
779,8,Skin angiosarcoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
779,9,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
779,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
779,11,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
780,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
781,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
781,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
781,3,Respiratory depth decreased,Breathing abnormalities,Respiratory disorders NEC,Resp,N
781,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
782,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
782,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
783,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
784,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
785,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
785,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
785,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
786,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
786,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
786,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
786,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
786,5,Right ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
786,6,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
787,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
787,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
787,3,Cardiac contractility decreased,Myocardial disorders NEC,Myocardial disorders,Card,N
787,4,Electrocardiogram QRS complex prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
787,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
788,1,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
788,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
789,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
789,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
790,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
790,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
790,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
790,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
790,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
791,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
792,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
792,3,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
793,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
793,2,Hyperinsulinaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
793,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
793,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
794,1,Thalamus haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
794,2,Vascular access site pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
795,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
795,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
795,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
795,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
796,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
796,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
796,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
797,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
797,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
798,1,Coagulation time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
798,2,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
798,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
798,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
798,5,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
799,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
800,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
801,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
801,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
801,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
801,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
801,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
802,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
802,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
802,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
802,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
803,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
803,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
803,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
804,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
804,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
805,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
806,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
806,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
806,3,Spinal epidural haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
807,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
807,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
808,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
809,1,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
809,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
809,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
809,4,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
810,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
810,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
810,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
810,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
810,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
810,6,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
810,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
810,8,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
810,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
811,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
812,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
813,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
814,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
814,2,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
814,3,Subcapsular splenic haematoma,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
815,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
815,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
816,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
816,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
816,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
816,4,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
816,5,Mesenteric haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
817,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
817,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
817,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
818,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
818,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
819,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
819,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
819,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
820,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
820,2,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
821,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
821,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
821,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
821,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
822,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
823,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
823,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
823,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
824,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
825,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
826,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
827,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
828,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
828,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
828,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
829,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
830,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
830,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
830,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
831,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
831,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
832,1,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
833,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
833,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
834,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
834,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
835,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
835,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
835,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
835,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
835,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
836,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
837,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
837,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
837,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,4,Headache,Headaches NEC,Headaches,Nerv,N
837,5,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
837,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
837,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
837,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
837,9,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
837,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
838,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
838,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
839,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
839,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
840,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
840,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
841,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
841,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
841,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
841,4,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
841,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
841,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
841,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
841,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
841,9,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
842,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
842,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
842,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
842,4,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
842,5,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
842,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
842,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
842,8,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
842,9,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
843,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
843,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
843,3,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
843,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
843,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
843,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
844,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
844,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
845,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
846,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
846,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
846,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
847,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
847,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
848,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
849,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
849,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
849,3,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
850,1,Breast haematoma,Breast signs and symptoms,Breast disorders,Repro,N
850,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
851,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
851,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
851,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
851,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
852,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
852,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
852,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
853,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
853,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
853,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
853,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
853,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
854,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
854,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
854,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
854,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
854,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
854,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
854,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
855,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
855,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
856,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
857,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
858,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
859,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
860,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
861,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
862,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
863,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
864,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
865,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
866,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
867,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
867,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
867,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
867,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
867,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
868,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
869,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
870,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
871,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
872,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
872,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
872,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
872,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
872,5,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
872,6,Headache,Headaches NEC,Headaches,Nerv,N
872,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
872,8,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
873,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
874,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
874,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
874,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
874,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
875,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
876,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
877,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
877,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
877,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
877,4,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
878,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
878,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
879,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
879,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
879,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
879,4,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
880,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
880,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
881,1,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
882,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
882,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
882,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
882,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
882,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
883,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
883,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
883,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
884,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
884,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
884,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
884,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
884,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
885,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
885,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
885,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
885,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
885,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
886,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
886,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
886,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
886,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
886,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
887,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
887,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
887,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
887,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
887,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
888,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
888,2,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
889,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
889,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
889,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
889,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
889,6,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
890,1,Autoimmune heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
891,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
891,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
891,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
891,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
892,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
893,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
894,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
895,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
896,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
896,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
896,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
897,1,Autoimmune heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
898,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
898,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
898,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
898,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
898,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
898,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
898,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
898,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
898,9,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
898,10,Serratia sepsis,Serratia infections,Bacterial infectious disorders,Infec,N
898,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
899,1,Sarcopenia,Muscle weakness conditions,Muscle disorders,Musc,N
900,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
900,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
900,3,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
900,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
900,5,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
901,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
902,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
902,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
904,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
904,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
904,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
905,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
905,2,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
905,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
906,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
906,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
906,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
906,4,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
906,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
906,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
907,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
908,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
908,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
908,3,Electrocardiogram T wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
909,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
909,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
909,3,Electrocardiogram T wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
910,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
910,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
910,3,Electrocardiogram T wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
911,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
911,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
911,3,Electrocardiogram T wave abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
912,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
913,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
914,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
914,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
914,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
914,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
915,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
916,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
916,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
916,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
916,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
916,5,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
917,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
918,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
919,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
920,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
920,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
920,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
920,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
921,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
922,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
923,1,Necrotising soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
923,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
924,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
925,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
925,2,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
926,1,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
927,1,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
928,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
928,2,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
928,3,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
928,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
930,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
931,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
931,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
932,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
932,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
933,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
934,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
934,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
935,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
936,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
936,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
938,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
939,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
940,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
941,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
942,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
943,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
944,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
945,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
946,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
947,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
948,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
949,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
949,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
949,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
949,4,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
949,5,Glomerulonephritis minimal lesion,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
949,6,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
949,7,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
949,8,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
949,9,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
949,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
949,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
950,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
950,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
951,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
951,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
